Aspen Pharmacare Holdings Profit Margin

Aspen Pharmacare Holdings (APNHY) currently reports a profit margin of 1.97% as of June 2026. That compares with 9.85% in the prior-year period — down 80.0% year over year. That is below the Healthcare sector average of 13.71%. Use the charts on this page to explore Aspen Pharmacare Holdings's profit margin history and peer comparisons.

Aspen Pharmacare Holdings's profit margin decreased from 9.85% to 1.97% — a 80.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aspen Pharmacare Holdings's profit margin of 1.97% is lower than the Healthcare sector average of 13.71%. That is roughly 85.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Aspen Pharmacare Holdings's current 1.97% should be judged against Healthcare norms (sector average: 13.71%) and against APNHY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 1.97%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.71%. From there, open related valuation or income-statement pages for Aspen Pharmacare Holdings, and consider following APNHY for alerts when major investors trade the stock.